About BD
What BD is building
Funding rounds
Company type
BD news and updates
Becton, Dickinson, and Company launches Viva insulin pen needles
In July 2017, as a part of action of the Health Service Medical Supplies Act 2017, Becton, Dickinson and Company (BD) launched Viva insulin pen needles as a cost-effective option for people with diabetes to accommodate extreme budgetary pressure on the National Health Services (NHS).
Nov 21, 2022 | einnews.comBecton, Dickinson, and Company is developing Isla Visual Record for Surveillance
Becton Dickinson (BD) has announced a funding collaboration with Isla Care to further develop the Isla Visual Record for Surveillance.
Nov 18, 2022 | med-technews.comBecton, Dickinson, and Company partnered with Magnolia Medical on Oct 18th 22'.
Becton, Dickinson and Company (BD) has signed a co-exclusive commercial agreement with Magnolia Medical Technologies to help reduce blood culture contamination and improve testing accuracy in US hospitals.
Oct 18, 2022 | medicaldevice-network.comBecton, Dickinson, and Company has issues with recall of 17 versions of its sterilization containers
Oct 7 (Reuters) - Medical device-maker Becton Dickinson & Co has issued a voluntary recall of 17 versions of its sterilization containers, according to a Wall Street Journal report on Friday citing a company letter to customers sent this week.
Oct 6, 2022 | yahoo.comBecton, Dickinson, and Company has issues with cybersecurity vulnerability that could allow an attacker to access and modify information
Becton Dickinson has disclosed a cybersecurity vulnerability that could allow an attacker to access and modify information on an instrument used to process cervical cytology samples.
Oct 6, 2022 | medtechdive.comBecton, Dickinson, and Company is developing at-home COVID-19 rapid test using a BD antigen test and the Scanwell Health mobile app on Feb 1st 21'.
In February 2021, Becton, Dickinson and Company announced a collaboration to develop an at-home COVID-19 rapid test using a BD antigen test and the Scanwell Health mobile app.
Sep 21, 2022 | globenewswire.comBecton, Dickinson, and Company invested into assets : building in the amount of $200M in Zaragoza, Spain on May 1st 21'.
In May 2021, Becton, Dickinson, and Company announced that they are planning to invest approximately USD 200.0 million in a new building in Zaragoza, Spain, the new facility will support the growth of a pre-completed drug delivery business.
Sep 14, 2022 | theuavdigest.comBecton, Dickinson, and Company launches next-generation glass prefillable syringe for vaccine PFS
Becton, Dickinson and Company ( NYSE: BDX ) said it launched a next-generation glass prefillable syringe (PFS) for vaccine PFS with tightened specifications for processability and contamination.
Sep 13, 2022 | seekingalpha.comBecton, Dickinson, and Company expanded facilities to Johnston, Rhode Island, United States on Jan 1st 10'.
Medical device and products maker Becton Dickinson (BD) will spend up to $30 million to open a new manufacturing facility at the Four Oaks Business Park in Johnston County, NC, a local economic development organization announced Tuesday.
Sep 6, 2022 | plasticstoday.comBecton, Dickinson, and Company expands facilities to Cuautitlán Izcalli, Mexico
Becton Dickinson (BD) inaugurated a new building at its Pharmaceutical Systems plant in Cuautitlán Izcalli, State of Mexico.
Aug 30, 2022 | mexicanpharmaforum.comCampion left Becton, Dickinson, and Company as Executive Vice President and President of the Medical segment on Jul 25th 22'.
Campion joins Dentsply Sirona from Becton, Dickinson and Company (“BD”), where he most recently served as Executive Vice President and President of the Medical segment and prior to that served as President of the Interventional segment following BD’s acquisition of C. R. Bard.
Aug 24, 2022 | dentaltown.comBecton, Dickinson, and Company launches Tender Offers
Becton, Dickinson and Company (NYSE: BDX ) (the " Company " or " BD ") today announced the early tender results for its previously announced Tender Offers (as defined below) to purchase for cash certain of its outstanding debt securities listed in the table below.
Aug 22, 2022 | prnewswire.comBecton, Dickinson, and Company partners with U.S. Department of Labor
Becton, Dickinson and Company (BD) has reportedly entered into a conciliation agreement with the U.S. Department of Labor’s Office of Federal Contract Compliance Programs to resolve alleged hiring discrimination at three of its plants.
Jun 28, 2022 | columbustelegram.comBecton, Dickinson, and Company launched BD Intevia 1mL two-step disposable autoinjector on Oct 1st 19'.
October 2019: BD (Becton, Dickinson, and Company) announced the launch of the BD Intevia 1mL two-step disposable autoinjector.
Feb 16, 2022 | medgadget.comBecton, Dickinson, and Company will hire Shana Neal as chief people officer on Apr 4th 22'.
BD (Becton, Dickinson and Company), a global medical technology company, announced that Shana Neal has been appointed chief people officer, effective April 4, 2022.
Jan 1, 2022 | hrnxt.comBecton, Dickinson, and Company increases headcount by 300
With an investment of HUF 70 billion (EUR 184 million), the US medical technology company, Becton Dickinson is creating 300 new jobs in Környe.
Jan 1, 2022 | doing-business-in-hungary.comBecton, Dickinson, and Company will launch Embecta spinoff on Apr 1st 22'.
Becton Dickinson & Co. is still on track to launch its Embecta spinoff on April 1.
Jan 1, 2022 | mddionline.comBecton, Dickinson, and Company launched BD Rhapsody TCR/BCR Multiomic Assay on Feb 28th 22'.
FRANKLIN LAKES, N.J. - BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, recently released the BD Rhapsody TCR/BCR Multiomic Assay, an innovative set of reagents that enables researchers to more easily and comprehensively analyze important cells in the immune system, providing a tool to advance research in autoimmune disorders, immuno-oncology and infectious diseases.
Jan 1, 2022 | marketscreener.comBecton, Dickinson, and Company is developing Isla Visual Record for Surveillance’ – a platform
Becton Dickinson has announced a funding collaboration with Isla Care, to further develop the ‘Isla Visual Record for Surveillance’ – a platform used post-surgery.
Jan 1, 2022 | pharmatimes.comBecton, Dickinson, and Company launches BD Horizon RealYellow 586 Reagents
(Credit: PRNewswire/ BD (Becton, Dickinson and Company)) Becton, Dickinson and Company (BD) has introduced a new range of reagents, BD Horizon RealYellow 586 Reagents.
Jan 1, 2022 | nsmedicaldevices.comBecton, Dickinson, and Company launches high-throughput molecular diagnostic combination test for SARS-CoV-2 and Influenza A/B, the second test available for the BD COR PX/MX System
New Delhi: BD (Becton, Dickinson and Company, a leading global medical technology company, has launched a new high-throughput molecular diagnostic combination test for SARS-CoV-2 and Influenza A/B, the second test available for the BD COR™ PX/MX System to have been CE marked to the IVD directive 98/79/EC.
Jan 1, 2022 | biovoicenews.comBecton, Dickinson, and Company launches BD Stevia
Becton, Dickinson and Company (BD) have introduced the BD Stevia, a revolutionary two-step disposable auto-injector.
Jan 1, 2022 | digitaljournal.comBecton, Dickinson, and Company will acquire Parata Systems, LLC for $1.52B on Jun 13th 22'.
Becton, Dickinson and Company ( NYSE: BDX ) and Frazier Healthcare Partners have signed a definitive agreement to acquire Parata Systems, innovative provider of pharmacy automation solutions.
Jan 1, 2022 | seekingalpha.comBecton, Dickinson, and Company has issues with recall of its Intraosseous Needle Set Kits
Becton Dickinson & Co. has announced a voluntary recall of its Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits and Intraosseous Powered Drivers.
Jan 1, 2022 | mddionline.comBecton, Dickinson, and Company is developing at-home rapid test for SARS-CoV-2 on Feb 1st 21'.
In February 2021, Becton, Dickinson and Company collaborated with Scanwell Health, a provider of smartphone-enabled at-home medical tests, to develop an at-home rapid test for SARS-CoV-2 using Becton, Dickinson and Company’s antigen test and Scanwell Health’s mobile app.
Jan 1, 2022 | einnews.comBecton, Dickinson, and Company hired Rishi Grover as EVP and chief integrated supply chain officer on Jul 7th 22'.
BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, today announced that Rishi Grover has been named executive vice president (EVP) and chief integrated supply chain officer for BD, effective July 7, 2022.
Jan 1, 2022 | prnewswire.comBecton, Dickinson, and Company will launch SANKALP on Jan 1st 25'.
To support the goal of eliminating Tuberculosis elimination in India by 2025, Becton Dickinson (BD) India has launched SANKALP – a ‘ Pledge to Fight TB Together ’.
Jan 1, 2022 | pahlikiran.comBecton, Dickinson, and Company acquires MedKeeper LLC
US-based medical technology company Becton, Dickinson and Company (BD) has acquired MedKeeper to provide cloud-based, connected pharmacy software.
Jan 1, 2022 | practical-patient-care.comBecton, Dickinson, and Company partnered with Accelerate Diagnostics, Inc. on Aug 15th 22'.
Becton Dickinson announced on Monday that it has inked a deal with Accelerate Diagnostics to sell that firm's Accelerate Pheno system and the Accelerate Arc module for antimicrobial susceptibility testing.
Jan 1, 2022 | 360dx.comBecton, Dickinson, and Company partnered with USA Swimming on May 16th 21'.
Becton, Dickinson and Company BDX, popularly known as BD, recently partnered with USA Swimming –the national governing body for the sport of swimming in the United States.
Jan 1, 2021 | companynewshq.comBecton, Dickinson, and Company partners with Everly Health
Becton, Dickinson and Company (BD) has partnered with digital health company Everly Health, Southeastern Grocers and Winn-Dixie stores to offer its Veritor At-Home COVID-19 Test for purchase.
Jan 1, 2021 | medicaldevice-network.comBecton, Dickinson & Co has issues with serious injuries and at least one death
Between 2019 and 2020, Becton, Dickinson and Company (BD) recalled millions of its BD Alaris System devices for defective software, hardware and other issues because of serious injuries and at least one death.
Oct 21, 2020 | drugwatch.comBecton, Dickinson, and Company received financing of $24M in investment on Jul 30th 20'.
Becton, Dickinson receives $24m investment from the U.S. govt to support the scale-up of U.S. manufacturing capabilities for its rapid Covid-19 test.
Jan 1, 2020 | bloomberglaw.comBecton, Dickinson, and Company partners with Certest Biotec
Becton, Dickinson and Company (BD) has announced a collaboration with CerTest Biotec for the development of a molecular diagnostic test for the monkeypox virus.
Jan 1, 2020 | medicaldevice-network.comLondon School of Hygiene & Tropical Medicine partnered with Becton, Dickinson, and Company on Nov 4th 19'.
Monday Nov 4 marks the worldwide launch of “The Role of Diagnostics in the AMR Response,” a massive open online course (MOOC) developed by the London School of Hygiene and Tropical Medicine, in partnership with Becton Dickinson and Company.
Jan 1, 2019 | idc-dx.net